AstraZeneca PLC (AZN.L): Pipeline still looks full. Raising EPS 1-3% and TP to £178

Research evidence excerpt

AstraZeneca PLC (AZN.L): Pipeline still looks full. Raising EPS 1-3% and TP to £178

he substance or in preparation of the

Product. Please contact your Citigold//Citigold Private Client Relationship Manager in CSL if you have any queries on or any

matters arising from or in connection with this document. The Product is intended for recipients who are accredited investors

as defined under the Securities and Futures Act (Cap. 289).

Citigroup Global Markets (Pty) Ltd. is incorporated in the Republic of South Africa (company registration number

2000/025866/07) and its registered office is at 145 West Street, Sandton, 2196, Saxonwold. Citigroup Global Markets (Pty)

Ltd. is regulated by JSE Securities Exchange South Africa, South African Reserve Bank and the Financial Services Board. The

investments and services contained herein are not available to private customers in South Africa.

The Product is made available in the Republic of China (Taiwan) through Citigroup Global Markets Taiwan Securities

Company Ltd. ("CGMTS"), 14F, 15F and 16F, No. 1, Songzhi Road, Taipei 110, Taiwan, subject to the license scope and the

applicable laws and regulations in the Republic of China (Taiwan). CGMTS is regulated by the Securities and Futures Bureau of

the Financial Supervisory Commission of Taiwan, the Republic of China (Taiwan). No portion of the Product may be reproduced

or quoted in the Republic of China (Taiwan) by the press or any third parties [without the written authorization of CGMTS].

Pursuant to the applicable laws and regulations in the Republic of China (Taiwan), the recipient of the Product shall not take

advantage of such Product to involve in any matters in which the recipient may have conflicts of interest. If the Product covers